HeartSciences Free Cash Flow (FCF) History (HSCS)

HeartSciences reported −$7.4M in free cash flow for fiscal 2025, a decrease of $1.3M from the previous fiscal year, with a free cash flow margin of −170486.23%.

View full HeartSciences company overview

HeartSciences free cash flow by year

HeartSciences annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-04-30−$7.4M−$1.3M−170486.23%
20242024-04-30−$6.1M−$342,755−32981.94%
20232023-04-30−$5.8M−$2.1M−112463.79%
20222022-04-30−$3.6M−25367.54%

HeartSciences free cash flow growth trends

HeartSciences's latest reported quarter, Q3 2026, generated −$1.5M in free cash flow, a decrease of $481,863 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review HeartSciences filings at SEC.gov ↗